APA (7th ed.) Citation

R, V., ME, R., C, B., A, O., J, G., O, T., . . . L, O. (2021). Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy. Frontiers in oncology, 10, 589218. https://doi.org/10.3389/fonc.2020.589218

Chicago Style (17th ed.) Citation

R, Vázquez, Riveiro ME, Berenguer-Daizé C, O'Kane A, Gormley J, Touzelet O, Rezai K, Bekradda M, and Ouafik L. "Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy." Frontiers in Oncology 10 (2021): 589218. https://doi.org/10.3389/fonc.2020.589218.

MLA (9th ed.) Citation

R, Vázquez, et al. "Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy." Frontiers in Oncology, vol. 10, 2021, p. 589218, https://doi.org/10.3389/fonc.2020.589218.